Company Information
Member Since 5 Years
Nature of Business Supplier Year of Establishment 2009Ask for more detail from the seller
Contact Supplier
Tirzepatide is a novel first-in-class drug that is used to treat type 2 diabetes and licensed in the US. The tirzepatide drug is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. GIP and GLP-1 are hormones called incretins that are released by the intestines.
Both GIP and GLP-1 increase the production of insulin, with GLP-1 promoting a feeling of fullness and delaying stomach emptying and controlling appetite.
GIP has an effect to reduce fat accumulation, increases bone formation, increases glucagon production, and reduces acid secretion in the stomach.
The combination of GIP and GLP-1 agonists makes tirzepatide a unqiue and very effective medication.
The medication is administered as a once weekly subcutaneous injection into the midriff, upper arm or thigh.
The medication is titrated on a 5mg, 10mg and 15mg dosage dependant on blood sugar and the propensity for side effects from a patient.
Connect with us
For Buyer 
For Seller 
Help 
Amsterdam 
Send Enquiry